Zachary S. Wallace

Rheumatology

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 236 publications

B-Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID-19 Among Autoimmune Disease Patients: A Matched Prospective Cohort Study.

B-Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID-19 Among Autoimmune Disease Patients: A Matched Prospective Cohort Study.

Journal: ACR open rheumatology

Published: June 17, 2026

Development and initial validation of a brief measure of uncertainty in rheumatic disease.

Development and initial validation of a brief measure of uncertainty in rheumatic disease.

Journal: Journal of health psychology

Published: January 31, 2026

Differences in SARS-CoV-2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER-Adult Cohort Study.

Differences in SARS-CoV-2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER-Adult Cohort Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 04, 2025

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.

Journal: JCI insight

Published: November 25, 2025

Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients.

Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients.

Journal: Vaccines

Published: July 24, 2025

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease.

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease.

Journal: Seminars in arthritis and rheumatism

Published: July 23, 2025

Real-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysis.

Real-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysis.

Journal: Medicine

Published: June 16, 2025

Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease.

Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease.

Journal: Annals of the rheumatic diseases

Published: June 06, 2025

A genotype-phenotype transformer to assess and explain polygenic risk.

A genotype-phenotype transformer to assess and explain polygenic risk.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2025

Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.

Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: April 08, 2025

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: Baseline results of SAIL-RA.

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: Baseline results of SAIL-RA.

Journal: medRxiv : the preprint server for health sciences

Published: February 20, 2025

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA.

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA.

Journal: The Lancet. Rheumatology

Published: February 12, 2025

Showing 1-12 of 236

Last Updated: 09/26/2026